Skip to content

Brief Negotiated Interview (BNI) for dropouts from Opioid Agonist Treatment: An open-label, randomized controlled trial

The Efficacy of a Telephonic Brief Negotiated Interview (BNI) on re-entry of dropouts from Opioid Agonist Treatment: An open label, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061387
Enrollment
100
Registered
2024-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F112- Opioid dependence

Interventions

Intervention1: TELEPHONIC BRIEF NEGOTIATED INTERVIEW: A telephonic brief negotiated interview lasting 15-20 minutes to motivate dropouts from opioid agonist treatment to re-enter treatment Control In

Sponsors

DR ROSHAN BHAD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Registered in the clinic in the two-year period before the selection month, Having a working mobile phone number, Diagnosed as suffering from opioid dependence syndrome as per ICD 10, Initiated on OAT at least one month before the assessment date, Unilaterally discontinued medicine by not receiving even a single dose of OAT medicine in the 30-days period before the intervention period, Use of illicit opioids at least once in last 30 days

Exclusion criteria

Exclusion criteria: Drop out due to migration, incarceration, under treatment for SUD/Medical illnesses or death, Presence of psychiatric/physical morbidity affecting telephonic interview, Not willing to take part in the interview

Design outcomes

Primary

MeasureTime frame
To compare the proportion of drop-out participants re-entering treatment after receiving telephonic brief negotiated interview with the proportion of drop-out participants re-entering treatment who received simple adviceTimepoint: 1 month and 3 months post intervention

Secondary

MeasureTime frame
To assess the number of days patient remains in treatment after re-entryTimepoint: within 3 months of re-entry

Countries

India

Contacts

Public ContactDR AJNEET BHARTI

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

drroshansindia@gmail.com9717756119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026